Skip to content

Comera Life Sciences Holdings, Inc.

CIK 0001907685

← back to feed
Revenue (TTM)
$1.08M
+97.9% YoY Q3 Nov 2023
Net Income (TTM)
−$9.12M
−230.2% YoY Q3 Nov 2023
EPS Diluted (TTM)
−$0.51
+2.8% YoY Q3 Nov 2023
Gross Margin
74.5%
Q3 Nov 2023
Operating Margin
-803.7%
Q3 Nov 2023
Net Margin
-845.4%
Q3 Nov 2023
Free Cash Flow (TTM)
−$9.8M
Q3 Nov 2023
Cash
$1.77M
Q3 Nov 2023
Total Debt
$389.87K
Q3 Nov 2023
Shares Outstanding
30.74M sh
Q3 Nov 2023

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings